EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome

doi:10.1097/GIM.0b013e31818fa2db

Review

. 2009 Jan;11(1):42-65.

doi: 10.1097/GIM.0b013e31818fa2db.

EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome

Glenn E Palomaki¹, Monica R McClain, Stephanie Melillo, Heather L Hampel, Stephen N Thibodeau

Affiliations

Affiliation

¹ Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School of Brown University, Women and Infants Hospital, Providence, Rhode Island, USA. gpalomaki@ipmms.org

PMID: 19125127
PMCID: PMC2743613
DOI: 10.1097/GIM.0b013e31818fa2db

Free PMC article

Review

EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome

Glenn E Palomaki et al. Genet Med. 2009 Jan.

Free PMC article

. 2009 Jan;11(1):42-65.

doi: 10.1097/GIM.0b013e31818fa2db.

Authors

Glenn E Palomaki¹, Monica R McClain, Stephanie Melillo, Heather L Hampel, Stephen N Thibodeau

Affiliation

¹ Department of Pathology and Laboratory Medicine, The Warren Alpert Medical School of Brown University, Women and Infants Hospital, Providence, Rhode Island, USA. gpalomaki@ipmms.org

PMID: 19125127
PMCID: PMC2743613
DOI: 10.1097/GIM.0b013e31818fa2db

No abstract available

PubMed Disclaimer

Cited by

Era of universal testing of microsatellite instability in colorectal cancer.
Zhang X, Li J. Zhang X, et al. World J Gastrointest Oncol. 2013 Feb 15;5(2):12-9. doi: 10.4251/wjgo.v5.i2.12. World J Gastrointest Oncol. 2013. PMID: 23556052 Free PMC article.
Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan.
Chen YE, Kao SS, Chung RH. Chen YE, et al. PLoS One. 2016 Aug 2;11(8):e0160599. doi: 10.1371/journal.pone.0160599. eCollection 2016. PLoS One. 2016. PMID: 27482709 Free PMC article.
History, genetics, and strategies for cancer prevention in Lynch syndrome.
Kastrinos F, Stoffel EM. Kastrinos F, et al. Clin Gastroenterol Hepatol. 2014 May;12(5):715-27; quiz e41-3. doi: 10.1016/j.cgh.2013.06.031. Epub 2013 Jul 23. Clin Gastroenterol Hepatol. 2014. PMID: 23891921 Free PMC article. Review.
Genetic Predisposition to Colorectal Cancer: How Many and Which Genes to Test?
Rebuzzi F, Ulivi P, Tedaldi G. Rebuzzi F, et al. Int J Mol Sci. 2023 Jan 21;24(3):2137. doi: 10.3390/ijms24032137. Int J Mol Sci. 2023. PMID: 36768460 Free PMC article. Review.
Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system.
Crain PR, Zepp JM, Gille S, Jenkins L, Kauffman TL, Shuster E, Goddard KAB, Wilfond BS, Hunter JE. Crain PR, et al. Hered Cancer Clin Pract. 2022 Apr 18;20(1):17. doi: 10.1186/s13053-022-00217-1. Hered Cancer Clin Pract. 2022. PMID: 35436948 Free PMC article.

See all "Cited by" articles

References

1. Bonis PA, Trikalinos TA, Chung M, et al. Hereditary nonpolyposis colorectal cancer: accuracy of diagnostic strategies and implications to patients with colorectal cancer and their families. Rockville, MD: Agency for Healthcare Research and Quality; 2007. Evidence report/technology assessment No. 07-E008.
1. EGAPP Working Group. Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med. 2009;11:35–41. - PMC - PubMed
1. Jass JR. Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term. World J Gastroenterol. 2006;12:4943–4950. - PMC - PubMed
1. Lindor NM, Rabe K, Petersen GM, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA. 2005;293:1979–1985. - PMC - PubMed
1. Terdiman JP. It is time to get serious about diagnosing Lynch syndrome (hereditary nonpolyposis colorectal cancer with defective DNA mismatch repair) in the general population. Gastroenterology. 2005;129:741–744. - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Bonis PA, Trikalinos TA, Chung M, et al. Hereditary nonpolyposis colorectal cancer: accuracy of diagnostic strategies and implications to patients with colorectal cancer and their families. Rockville, MD: Agency for Healthcare Research and Quality; 2007. Evidence report/technology assessment No. 07-E008.

[2] Bonis PA, Trikalinos TA, Chung M, et al. Hereditary nonpolyposis colorectal cancer: accuracy of diagnostic strategies and implications to patients with colorectal cancer and their families. Rockville, MD: Agency for Healthcare Research and Quality; 2007. Evidence report/technology assessment No. 07-E008.

[3] EGAPP Working Group. Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med. 2009;11:35–41. - PMC - PubMed

[4] EGAPP Working Group. Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med. 2009;11:35–41. - PMC - PubMed

[5] Jass JR. Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term. World J Gastroenterol. 2006;12:4943–4950. - PMC - PubMed

[6] Jass JR. Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term. World J Gastroenterol. 2006;12:4943–4950. - PMC - PubMed

[7] Lindor NM, Rabe K, Petersen GM, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA. 2005;293:1979–1985. - PMC - PubMed

[8] Lindor NM, Rabe K, Petersen GM, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA. 2005;293:1979–1985. - PMC - PubMed

[9] Terdiman JP. It is time to get serious about diagnosing Lynch syndrome (hereditary nonpolyposis colorectal cancer with defective DNA mismatch repair) in the general population. Gastroenterology. 2005;129:741–744. - PubMed

[10] Terdiman JP. It is time to get serious about diagnosing Lynch syndrome (hereditary nonpolyposis colorectal cancer with defective DNA mismatch repair) in the general population. Gastroenterology. 2005;129:741–744. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome

Affiliation

EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome

Authors

Affiliation

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical

Similar articles

Cited by

References

Publication types

MeSH terms

Related information

LinkOut - more resources

Full Text Sources

Medical